Literature DB >> 20042209

Accelerated evolution of SIV env within the cerebral compartment in the setting of morphine-dependent rapid disease progression.

Vanessa Rivera-Amill1, Richard J Noel, Yashira García, Ivelisse Rivera, Marcus Iszard, Shilpa Buch, Anil Kumar.   

Abstract

Human immunodeficiency virus-1 (HIV-1) and simian immunodeficiency virus (SIV) have been shown to compartmentalize within various tissues, including the brain. However, the evolution of viral quasispecies in the setting of drug abuse has not been characterized. The goal of this study was to examine viral evolution in the cerebral compartment of morphine-dependent and control macaques to determine its role in rapid disease progression. To address this issue, we analyzed the envelope (env) gene from proviral DNA in our SIV/SHIV macaque model of morphine dependence and AIDS. Analyses of proviral DNA revealed a direct correlation between total genetic changes and survival time. However, the rate of evolution during disease progression was higher in morphine-dependent and rapid-progressor macaques than was the rate of evolution in the control animals. This study provides additional insight into SIV envelope variation in the CNS of morphine-dependent macaques and genotypes that may have evolved in the brain and contributed to disease progression. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042209      PMCID: PMC2828616          DOI: 10.1016/j.virol.2009.11.046

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Authors:  R R Amara; F Villinger; J D Altman; S L Lydy; S P O'Neil; S I Staprans; D C Montefiori; Y Xu; J G Herndon; L S Wyatt; M A Candido; N L Kozyr; P L Earl; J M Smith; H L Ma; B D Grimm; M L Hulsey; J Miller; H M McClure; J M McNicholl; B Moss; H L Robinson
Journal:  Science       Date:  2001-04-06       Impact factor: 47.728

Review 2.  Injection drug use and HIV/AIDS transmission in China.

Authors:  Tian Xin Chu; Judith A Levy
Journal:  Cell Res       Date:  2005 Nov-Dec       Impact factor: 25.617

3.  Simian immunodeficiency virus envelope compartmentalizes in brain regions independent of neuropathology.

Authors:  Maria F Chen; Susan Westmoreland; Elena V Ryzhova; Julio Martín-García; Samantha S Soldan; Andrew Lackner; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

4.  SIV Vpr evolution is inversely related to disease progression in a morphine-dependent rhesus macaque model of AIDS.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

5.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.

Authors:  Rakesh Kumar; Suheydi Orsoni; Lisa Norman; Ashish S Verma; Grissell Tirado; Luis D Giavedoni; Silvija Staprans; Gregory M Miller; Shilpa J Buch; Anil Kumar
Journal:  Virology       Date:  2006-07-28       Impact factor: 3.616

7.  Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.

Authors:  Vanessa Rivera-Amill; Richard J Noel; Suheydi Orsini; Griselle Tirado; José M García; Shilpa Buch; Anil Kumar
Journal:  Virology       Date:  2006-09-28       Impact factor: 3.616

8.  Correlation between SIV Tat evolution and AIDS progression in cerebrospinal fluid of morphine-dependent and control macaques infected with SIV and SHIV.

Authors:  Richard J Noel; Ziomara Marrero-Otero; Rakesh Kumar; Gladys S Chompre-González; Ashish S Verma; Anil Kumar
Journal:  Virology       Date:  2006-04-27       Impact factor: 3.616

9.  Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.

Authors:  Richard J Noel; Anil Kumar
Journal:  Virology       Date:  2005-11-28       Impact factor: 3.616

Review 10.  Mechanisms of HIV-1 neurotropism.

Authors:  Rebecca Dunfee; Elaine R Thomas; Paul R Gorry; Jianbin Wang; Petronela Ancuta; Dana Gabuzda
Journal:  Curr HIV Res       Date:  2006-07       Impact factor: 1.581

View more
  6 in total

1.  Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.

Authors:  Shiping Zou; Sylvia Fitting; Yun-Kyung Hahn; Sandra P Welch; Nazira El-Hage; Kurt F Hauser; Pamela E Knapp
Journal:  Brain       Date:  2011-11-18       Impact factor: 13.501

2.  Identification and molecular characterization of SIV Vpr R50G mutation associated with long term survival in SIV-infected morphine dependent and control macaques.

Authors:  Ivelisse Rivera; Yashira García; Mohitkumar R Gangwani; Richard J Noel; Lucianette Maldonado; Anil Kumar; Vanessa Rivera-Amill
Journal:  Virology       Date:  2013-08-28       Impact factor: 3.616

3.  CD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo.

Authors:  Nicholas Francella; Sarah E Gwyn; Yanjie Yi; Bing Li; Peng Xiao; Sarah T C Elliott; Alexandra M Ortiz; James A Hoxie; Mirko Paiardini; Guido Silvestri; Cynthia A Derdeyn; Ronald G Collman
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

4.  Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability.

Authors:  Hongxiu Wen; Yaman Lu; Honghong Yao; Shilpa Buch
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

5.  Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors.

Authors:  Changqing Xu; Sylvia Fitting
Journal:  Front Neurosci       Date:  2016-11-08       Impact factor: 4.677

Review 6.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.